Surmodics

Surmodics Current Liabilities

Delisted

The Current Liabilities of Surmodics (SRDX) as of Sep 26, 2026 is 32.57 M USD. In the previous year, Current Liabilities was 36.16 M USD — a change of -9.91% (lower).

Current Liabilities

32.57 MUSD

YoY

-9.91%

Last updated:

Current Liabilities of Surmodics is 2026 32.57 M USD. Current Liabilities of Surmodics was 2025 36.16 M USD. It decreases by -9.91% lower compared to the previous year.

The Surmodics Current Liabilities history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Liabilities
Date
Current Liabilities
Jan 1, 2017
20.94 M USD
Jan 1, 2018
42.48 M USD
Jan 1, 2019
28.23 M USD
Jan 1, 2020
25.89 M USD
Jan 1, 2021
38.57 M USD
Jan 1, 2022
42.72 M USD
Jan 1, 2023
36.16 M USD
Jan 1, 2024
32.57 M USD
The Surmodics Current Liabilities history
YEARCurrent LiabilitiesYoY
32.57 MUSD-9.91%
36.16 MUSD-15.36%
42.72 MUSD+10.76%
38.57 MUSD+48.96%
25.89 MUSD-8.27%
28.23 MUSD-33.55%
42.48 MUSD+102.90%
20.94 MUSD-12.27%
23.86 MUSD+133.72%
10.21 MUSD+12.51%
9.08 MUSD-26.38%
12.33 MUSD-8.72%
13.50 MUSD-33.19%
20.21 MUSD+55.13%
13.03 MUSD+14.94%
11.34 MUSD-33.37%
17.01 MUSD-24.90%
22.65 MUSD+80.75%
12.53 MUSD+52.67%
8.21 MUSD-42.33%
14.23 MUSD+3.67%
13.73 MUSD+58.25%
8.68 MUSD+146.13%
3.53 MUSD-11.79%
4.00 MUSD+14.17%
3.50 MUSD+40.00%
2.50 MUSD+127.27%
1.10 MUSD+22.22%
900,000.00USD—
Access this data via the Eulerpool API
Get Free API Key

Surmodics Stock analysis

What does Surmodics do? Surmodics Inc is an American company specializing in medical technology, based in Eden Prairie, Minnesota. They focus on developing and commercializing technologies to improve disease diagnosis and treatment. The company offers a wide range of medical devices and solutions for various medical applications, including cardiology, radiology, oncology, ophthalmology, and pharmaceutical development. Surmodics operates in three main business areas: medical devices, hollow fiber technology, and bioactive coatings. Their products are designed to meet the specific needs of customers and medical applications. Surmodics has a strong global presence and has expanded through strategic acquisitions in recent years, particularly in the pharmaceutical development and hollow fiber technology sectors. Surmodics is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Surmodics stock

Current Liabilities of Surmodics is 32.57 M USD in 2026.

Current Liabilities of Surmodics changed from 36.16 M USD to 32.57 M USD, representing a -9.91% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Current Liabilities Surmodics since 2006 – with annual values, charts, and detailed analysis.

Current liabilities are obligations due within one year, including accounts payable, short-term debt, and accrued expenses.

Current Liabilities's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Liabilities's Surmodics historically and in real time.

Access this data via the Eulerpool API
Get Free API Key

Balance Sheet — Surmodics

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — Surmodics